El País interviews Altos Labs’ principal investigator Pura Muñoz Cánoves
El País - 27-Dec-2023Altos labs with a $3-billion budget pave the way for reversing aging and extending healthy lifespan
Altos Labs
Biotechnology company focused on cellular rejuvenation programming
Altos is dedicated to unraveling the deep biology of cellular rejuvenation programming. Our mission is to restore cell health and resilience to reverse disease, injury, and disabilities that occur throughout life.
The Altos Institutes of Science will pursue deep scientific questions and integrate their findings into one collaborative research effort. The Altos Institute of Medicine will capture knowledge generated about cell health and programming and develop transformative medicines.
Altos Labs Leadership
• Wolf Reik, Director, Cambridge Institute of Science
Altos Labs Institute of Science Cambridge
• Maria Abad
• Kevin Chalut
• Martin Denzel
• Robin Franklin
• Giovanna Mallucci
• Ken Raj
• Manuel Serrano
Visit website: https://altoslabs.com/
Details last updated 20-Jan-2022
Mentioned in this Resource
Martin Denzel
Principal Investigator at AltosLabs and researcher at Max Planck Institute for Biology of Ageing
Robin Franklin
Principal Investigator at Altos Labs Cambridge Institute of Science, previously Professor of Stem Cell Medicine
Other people at Altos Labs
Thore Graepel
Global Head of Computational Science, Artificial Intelligence and Machine Learning at Altos Labs
Hal Barron
President Research And Development at GSK, former president of research and development at Calico and incoming CEO at Altos Labs
Altos Labs News
Altos labs launches institute of computation to revolutionize medicine
Altos Labs - 09-Nov-2023Advancing computational biology to reprogram cells and transform the future of healthcare
UK biotech races US giants for longevity breakthrough
The Guardian - 05-Nov-2023British researchers and startups vie to outpace tech billionaires in the fight against ageing
Lifespan.io summarises the proceedings of the Buck Institute's Longevity Summit
Lifespan.io (LEAF) - 20-Jan-2023Another reminder of the amount of research, with multiple approaches, about to go into clinical trials
Umbilical cord blood derived plasma improves health biomarkers
Lifespan.io (LEAF) - 06-Sep-2022Plasma concentrate alters methylation clock reducing biological age
Ageing versus longevity: epigenetic age correlated with only a few ageing hallmarks
Live Forever Club - 08-Jun-2022Mitochondrial dysfunction & stem cell exhaustion accelerated the epigenetic clock, but senescent cells & telomere length did not
The Observer interviews Morgan Levine about ageing and her move to Altos Labs
The Guardian - 07-May-2022When it comes to lifespan, you cannot blame 100% on genetics, just 10-30%
Long-term partial reprogramming reversed ageing process in mice
The Guardian - 07-Mar-2022Yamanaka factors restored youthfullness in aged cells, raised hope for new anti-ageing therapies
Altos Labs comes out of stealth with $3 billion of capital
Genetic Engineering & Biotechnology News (GEN) - 19-Jan-2022Huge backing that cellular reprogramming can have a significant impact on health and ageing
Topics mentioned on this page:
Rejuvenation
